Previous close | 10.45 |
Open | 10.90 |
Bid | 9.55 |
Ask | 10.75 |
Strike | 38.00 |
Expiry date | 2024-05-17 |
Day's range | 10.35 - 10.45 |
Contract range | N/A |
Volume | |
Open interest | 171 |
Andrew Baum, the prominent Wall Street drug company analyst will be the pharma firm’s chief strategy and innovation officer.
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The pharmaceutical company posts a first-quarter loss of €1.31 a share, a swing from year-earlier profit of €2.05.